Close Menu

stock rating

NEW YORK (GenomeWeb News) – Investment bank William Blair has initiated coverage of Life Technologies with an Outperform rating, saying that the firm's stock is relatively inexpensive considering its "stable earnings growth and robust cash flow."

NEW YORK (GenomeWeb News) – Mizuho Securities has initiated coverage of Fluidigm and BG Medicine, placing a Buy rating on both firms.

NEW YORK (GenomeWeb News) – Goldman Sachs has placed a Buy rating on Hologic with a six-month price target on its stock of $24, as the Gen-Probe acquisition, completed a week ago, is expected to accelerate top line

NEW YORK (GenomeWeb News) – Leerink Swann today upgraded Illumina to an Outperform rating, saying the demand for its HiSeq next-generation sequencing platform has normalized, while interest among researchers in sequencing has remained high.

NEW YORK (GenomeWeb News) – Despite healthier than expected spending during the second quarter, life science researchers are expected to tighten their purse strings for the remainder of the year, according to the results of a survey conducted by investment firm Goldman Sachs.

NEW YORK (GenomeWeb News) – Investment bank Credit Suisse today upgraded Illumina's stock, citing the firm's improved financial performance over the past two quarters and the potential of its tools for the clinical market in the longer term.

NEW YORK (GenomeWeb News) – Investment bank Goldman Sachs has reinstated coverage of Illumina, giving it a Neutral rating and a 12-month price target on its stock of $48.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Citigroup upgraded Life Technologies to Buy today following last week's contraction in the company's stock price.

By a GenomeWeb staff reporter NEW YORK (GenomeWeb News) – Investment bank Leerink Swann today upgraded Life Technologies to Outperform, noting the potential growth of the company's next-generation sequencing business.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Citing expected organic growth and a continuing ramp up of QIAsymphony, investment bank JP Morgan today upgraded Qiagen to Overweight.

Pages

A bill passed by a US House of Representatives appropriations subcommittee would give scientific agencies including the National Science Foundation boosts in funding.

University of Idaho researchers model the scientific discovery process to examine the link between reproducibility and scientific truth.

Relocating USDA agencies outside of Washington, DC, may make them less effective, critics of the move tell NPR.

In PLOS this week: genes that help Borrelia burgdorferi survive in ticks, CiliaCarta collection of about 1,000 suspected cilia genes, and more.